Mr Wulff joined Novo Nordisk in 1998 in the logistic and planning
function. From 2001 to 2008 he held different managerial roles within
Novo Nordisk’s manufacturing organisation, Product Supply, before
being appointed senior vice president of Diabetes API in Product
Supply, Denmark. In 2012 Mr Wulff was appointed senior vice president
of the worldwide division Diabetes Finished Products. In 2013 he was
promoted senior vice president of Product Supply globally. In April
2015 Mr Wulff was promoted executive vice president and in 2019 with
an expanded responsibility covering Global IT and Quality Assurance.
Mr Wulff is chair of the board of Novo Nordisk Pharmatech A/S and a
member of the board of Ambu A/S, both in Denmark.
Mr Wulff is Danish national, born November 1970.